CTL in HCV reinfection after OLT: Allospecific or virus-specific or both?

Cutting edge: identification of hepatitis C virus-specific CD8+T cells restricted by donor HLA alleles following liver transplantation. Rosen HR, Hinrichs DJ, Leistikow RL, Callender G, Wertheimer AM, Nishimura MI, Lewinsohn DM. By necessity, human liver transplantation is performed across HLA barriers. As a result, intracellular infection of the allograft presents a unique immunologic challenge for the recipientʹs immune system. In this study, we describe the presence of HLA-A2-restricted, hepatitis C virus (HCV)-specific CD8+T cells in liver transplant recipients in whom the allograft is HLA-A2 positive and the recipient is HLA-A2 negative. These memory-effector T cells are recipient derived and recognize HCV peptide uniquely in the context of HLA-A2. Furthermore, these cells were absent before the transplant, suggesting that the allograft is capable of selectively expanding naive CD8+T cells. The in vitro specificity to donor HLA allele-restricted CD8+T cells suggests that these cells may function to control HCV spread in the allograft. [Abstract reproduced by permission of J Immunol 2004;173:5355–5359]